Rapporten

Dybdegående analyser af virksomhedsfinansiering, vækststrategier og markedsindsigt fra verdens mest innovative virksomheder

10 rapporter og tæller

Opdateret dagligt med den seneste markedsintelligens
Supply Chain
CatalystLaunch Software

CatalystLaunch Software raises $153M Series D at $464M valuation

CatalystLaunch Software secures $153M in Series D funding led by DST Global, reaching $464M valuation as it accelerates growth in the supply chain sector.

Jessica Martinez
May 8, 2024
0 min read$153M
Media
AccelerateStack Networks

AccelerateStack Networks raises $36M Series B at $153M valuation

AccelerateStack Networks secures $36M in Series B funding led by Coatue, reaching $153M valuation as it accelerates growth in the media sector.

Michael Rodriguez
Jun 8, 2024
0 min read$36M
AI/ML
AccelerateCore Software

AccelerateCore Software raises $42M Series C at $153M valuation

AccelerateCore Software secures $42M in Series C funding led by Index Ventures, reaching $153M valuation as it accelerates growth in the ai/ml sector.

Michael Rodriguez
Jan 8, 2025
0 min read$42M
Fundraising
Upstream Bio

Upstream Bio Raises $153M in Series B

Upstream Bio, a Biotech company based in Waltham, MA, has raised $153M in Series B at a $800M valuation led by Fidelity, Viking Global.

Fundraising News Team
Sep 10, 2024
0 min read
Fundraising
Strand Therapeutics

Strand Therapeutics Raises $153M in Series B

Strand Therapeutics, a HealthTech company based in Cambridge, MA, has raised $153M in Series B led by Kinnevik, Regeneron Ventures, ICONIQ, Amgen Ventures.

Fundraising News Team
Aug 7, 2025
0 min read
Fundraising
Arthrosi Therapeutics

Arthrosi Therapeutics Raises $153M in Series E

Arthrosi Therapeutics, a Biotech company based in San Diego, CA, has raised $153M in Series E at a $800M valuation led by New Enterprise Associates, RA Capital.

Fundraising News Team
Oct 8, 2025
0 min read
Biotech
Strand Therapeutics

Strand Therapeutics Raises $153M Series B to Transform Biotech

Strand Therapeutics has secured $153M Series B in funding to accelerate growth and innovation in the biotech sector. Synthetic biology company programming mRNA therapies with logic-gated controls for precision oncology treatments...

David Chen
Oct 22, 2025
0 min read$153M Series B
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read$153M
Biotech
Upstream Bio

Upstream Bio raises $153M Series B at $800M valuation

Upstream Bio raises $153M in Series B at $800M valuation. Developing antibody therapeutics for inflammatory diseases...

Editorial Team
Sep 10, 2024
0 min read$153M
Side 1

Viser 9 rapporter • Side 1 • Kategori: all

Hold dig foran markedet

Få ugentlig indsigt leveret til din indbakke. Ingen spam, kun intelligens.